tiprankstipranks
Trending News
More News >
RedHill Biopharma (RDHL)
NASDAQ:RDHL
US Market

RedHill Biopharma (RDHL) Financial Statements

Compare
872 Followers

RedHill Biopharma Financial Overview

RedHill Biopharma's market cap is currently $6.82M. The company's EPS TTM is $-2.318; its P/E ratio is ―; RedHill Biopharma is scheduled to report earnings on September 5, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 8.04M$ 6.53M$ 61.80M$ 85.76M$ 64.36M
Gross Profit$ 4.85M$ 3.07M$ 28.46M$ 36.35M$ 27.47M
Operating Income$ -14.61M$ 12.63M$ -42.84M$ -81.14M$ -63.68M
EBITDA$ -7.59M$ 26.27M$ -22.18M$ -63.03M$ -54.98M
Net Income$ -8.27M$ 23.92M$ -71.67M$ -97.74M$ -76.17M
Balance Sheet
Cash & Short-Term Investments$ 4.62M$ 6.36M$ 19.98M$ 38.00M$ 29.79M
Total Assets$ 18.04M$ 23.05M$ 158.87M$ 181.19M$ 180.24M
Total Debt$ 356.00K$ 1.17M$ 122.69M$ 87.81M$ 86.90M
Net Debt$ -4.26M$ -4.40M$ 102.72M$ 58.34M$ 57.61M
Total Liabilities$ 22.73M$ 20.98M$ 207.27M$ 172.31M$ 166.38M
Stockholders' Equity$ -4.68M$ 2.07M$ -48.40M$ 8.88M$ 13.86M
Cash Flow
Free Cash Flow$ -9.38M$ -35.83M$ -29.38M$ -65.16M$ -102.35M
Operating Cash Flow$ -9.37M$ -35.82M$ -29.18M$ -65.05M$ -48.58M
Investing Cash Flow$ -9.00K$ 3.99K$ 8.30M$ -8.14M$ -35.65M
Financing Cash Flow$ 8.42M$ 21.38M$ 11.45M$ 73.46M$ 84.37M
Currency in USD

RedHill Biopharma Earnings and Revenue History

RedHill Biopharma Debt to Assets

RedHill Biopharma Cash Flow

RedHill Biopharma Forecast EPS vs Actual EPS